Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.53)
# 882
Out of 5,050 analysts
85
Total ratings
43.53%
Success rate
7.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.13 | +275.59% | 4 | Jun 4, 2025 | |
| AURA Aura Biosciences | Assumes: Buy | $22 | $5.35 | +311.21% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.28 | +681.25% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $10.52 | +280.23% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.09 | +817.43% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $2.27 | +164.32% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.36 | +198.17% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $2 | $0.82 | +145.01% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $4.29 | +436.13% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $39.68 | +89.01% | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $9.73 | +269.99% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $6 | $2.09 | +187.08% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.15 | +1,204.35% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $6.06 | +312.54% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $28.95 | +72.71% | 13 | Nov 26, 2024 |
ImmunityBio
Jun 4, 2025
Reiterates: Buy
Price Target: $8
Current: $2.13
Upside: +275.59%
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $5.35
Upside: +311.21%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $10.52
Upside: +280.23%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.09
Upside: +817.43%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $2.27
Upside: +164.32%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.36
Upside: +198.17%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $2
Current: $0.82
Upside: +145.01%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $4.29
Upside: +436.13%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $39.68
Upside: +89.01%
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $9.73
Upside: +269.99%
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.09
Upside: +187.08%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.15
Upside: +1,204.35%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $6.06
Upside: +312.54%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $28.95
Upside: +72.71%